Micreos, a Wageningen, The Netherlands-based developer of phage technology for targeted control of bacteria.
Micreos has raised €87M across 3 funding rounds, most recently a round in Oct 2022. Based in Wageningen, Netherlands; founded 2006; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-10-25 | Other | €25M | — | View deal → |
| 2021-10-01 | Other | €32M | — | View deal → |
| 2019-04-01 | Other | €30M | — | View deal → |
